Detalhe da pesquisa
1.
Quantitative Nuclear Grading: An Objective, Artificial Intelligence-Facilitated Foundation for Grading Noninvasive Papillary Urothelial Carcinoma.
Lab Invest
; 103(7): 100155, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059267
2.
Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy.
Eur Urol Open Sci
; 57: 22-29, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020525
3.
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers.
J Histochem Cytochem
; 70(5): 357-375, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437049
4.
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer.
J Pathol Clin Res
; 8(2): 143-154, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697907
5.
Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.
Eur Urol Open Sci
; 29: 50-58, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337534
6.
Building a Canadian Translational Bladder Cancer Research Network.
Can Urol Assoc J
; 14(10): E475-E481, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275556